Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial).

Mohammad S Kuchay et al.PubMed ↗Publisher ↗

The primary results report of NCT03590626.

What the trial testedas reported · 64 people · 2020

Not counted

−13.1U/l−24.4 to −1.80

As reported

difference −13.1 U/l, 95% CI −24.4 to −1.80

the abstract, start to end

… levels (mean between-group difference -13.1 U/l [95% CI -24.4, -1.8]; …

← favours treatmentfavours comparator →

could be chance

Liver & masld

−13.1−24.4 to −1.80

GLP-1 receptor agonistsInsulinLiver & MASLD

1 / 3

2020

…

2021

2023

2024

2025

2026

this paperpooled ittrialcites it